Prognostic Implications of EGFR, p53, p16, Cyclin D1, and Bcl‐2 in Head and Neck Squamous Cell Carcinoma (HNSCC)

Denis Soulieres, Neil N. Senzer, Everett E. Vokes, Manuel Hidalgo, Sanjiv S. Agarwala, Lillian L. Siu, Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck Journal of Clinical Oncology. ,vol. 22, pp. 77- 85 ,(2004) , 10.1200/JCO.2004.06.075

Yosef Yarden, Axel Ullrich, Growth Factor Receptor Tyrosine Kinases Annual Review of Biochemistry. ,vol. 57, pp. 443- 478 ,(1988) , 10.1146/ANNUREV.BI.57.070188.002303

Oreste Gallo, Vieri Boddi, Anna Calzolari, Laura Simonetti, Massimo Trovati, Simonetta Bianchi, bcl-2 protein expression correlates with recurrence and survival in early stage head and neck cancer treated by radiotherapy. Clinical Cancer Research. ,vol. 2, pp. 261- 267 ,(1996)

Gary L. Clayman, Kim D. Steck, Dorothy L. Taylor, Timothy J. McDonnell, Adel K. El-Naggar, Mary Wang, Ta Jen Liu, Apoptosis Induction Mediated by Wild-Type p53 Adenoviral Gene Transfer in Squamous Cell Carcinoma of the Head and Neck Cancer Research. ,vol. 55, pp. 3117- 3122 ,(1995)

L. Licitra, R. Mesia, F. Rivera, É. Remenár, R. Hitt, J. Erfán, S. Rottey, A. Kawecki, D. Zabolotnyy, M. Benasso, S. Störkel, S. Senger, C. Stroh, J.B. Vermorken, Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study Annals of Oncology. ,vol. 22, pp. 1078- 1087 ,(2011) , 10.1093/ANNONC/MDQ588

N. Sugawa, A. J. Ekstrand, C. D. James, V. P. Collins, Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 8602- 8606 ,(1990) , 10.1073/PNAS.87.21.8602

Patrick Tassone, Matthew Old, Theodoros N. Teknos, Quintin Pan, p53-based therapeutics for head and neck squamous cell carcinoma Oral Oncology. ,vol. 49, pp. 733- 737 ,(2013) , 10.1016/J.ORALONCOLOGY.2013.03.447

Matthias Rössle, Claudia S Weber, Lena Züllig, Nicole Graf, Wolfram Jochum, Sandro J Stöckli, Holger Moch, Gerhard F Huber, EGFR expression and copy number changes in low T-stage oral squamous cell carcinomas. Histopathology. ,vol. 63, pp. 271- 278 ,(2013) , 10.1111/HIS.12175

Ralph H. Hruban, Yolanda J. Eby, Russell Correo, J. Michael Ruppert, David Sidransky, Peter van der Riet, R. Arturo Roa, John Hakim, Wayne Koch, Jay O. Boyle, The Incidence of p53 Mutations Increases with Progression of Head and Neck Cancer Cancer Research. ,vol. 53, pp. 4477- 4480 ,(1993)

Jan B. Vermorken, Ricard Mesia, Fernando Rivera, Eva Remenar, Andrzej Kawecki, Sylvie Rottey, Jozsef Erfan, Dmytro Zabolotnyy, Heinz-Roland Kienzer, Didier Cupissol, Frederic Peyrade, Marco Benasso, Ihor Vynnychenko, Dominique De Raucourt, Carsten Bokemeyer, Armin Schueler, Nadia Amellal, Ricardo Hitt, Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer The New England Journal of Medicine. ,vol. 359, pp. 1116- 1127 ,(2008) , 10.1056/NEJMOA0802656